Abstract
Currently, guidance by myocardial contrast echocardiography at the time of angiography is critical in identifying appropriate septal perforators for septal alcohol ablation (SEA) in patients with hypertrophic obstructive cardiomyopathy (HOCM). We evaluated whether there are other angiographic and/or echocardiographic markers that may identify suitable patients for SEA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
